[1]
M. Abbasi, “Improving compliance with baseline bone health assessment in postmenopausal women with hormone receptor-positive breast cancer receiving adjuvant letrozole: a clinical audit”, J Global Med, vol. 6, no. 1, p. e383, Jul. 2026.